TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Sulfonamides Market, Global Outlook and Forecast 2022-2028

Sulfonamides Market, Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 29 July 2022
  • Pages :63
  • Formats:
  • Report Code:SMR-7244359
OfferClick for best price

Best Price: $2600

Sulfonamides Market Size, Share 2022


Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but dont surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animals body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohns disease, etc.

This report contains market size and forecasts of Sulfonamides in Global, including the following market information:

The global Sulfonamides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intestinal Absorption Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sulfonamides include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sulfonamides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sulfonamides Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sulfonamides Market Segment Percentages, by Type, 2021 (%)

  • Intestinal Absorption
  • Intestinal Tract Difficult to Absorb
  • External Use

Global Sulfonamides Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sulfonamides Market Segment Percentages, by Application, 2021 (%)

  • Systemic Infection
  • Intestinal Infection
  • Burn Infection
  • Other Infections

Global Sulfonamides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sulfonamides Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Sulfonamides revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Sulfonamides revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Pfizer
  • Sanofi
  • Roche
  • Mylan
  • Teva
  • Bayer
  • Abbott
  • GlaxoSmithKline
  • Boehringer Ingelheim

Report Attributes Report Details
Report Title Sulfonamides Market, Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 63 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Sulfonamides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sulfonamides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sulfonamides Overall Market Size
2.1 Global Sulfonamides Market Size: 2021 VS 2028
2.2 Global Sulfonamides Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sulfonamides Players in Global Market
3.2 Top Global Sulfonamides Companies Ranked by Revenue
3.3 Global Sulfonamides Revenue by Companies
3.4 Top 3 and Top 5 Sulfonamides Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sulfonamides Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sulfonamides Players in Global Market
3.6.1 List of Global Tier 1 Sulfonamides Companies
3.6.2 List of Global Tier 2 and Tier 3 Sulfonamides Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Sulfonamides Market Size Markets, 2021 & 2028
4.1.2 Intestinal Absorption
4.1.3 Intestinal Tract Difficult to Absorb
4.1.4 External Use
4.2 By Type - Global Sulfonamides Revenue & Forecasts
4.2.1 By Type - Global Sulfonamides Revenue, 2017-2022
4.2.2 By Type - Global Sulfonamides Revenue, 2023-2028
4.2.3 By Type - Global Sulfonamides Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sulfonamides Market Size, 2021 & 2028
5.1.2 Systemic Infection
5.1.3 Intestinal Infection
5.1.4 Burn Infection
5.1.5 Other Infections
5.2 By Application - Global Sulfonamides Revenue & Forecasts
5.2.1 By Application - Global Sulfonamides Revenue, 2017-2022
5.2.2 By Application - Global Sulfonamides Revenue, 2023-2028
5.2.3 By Application - Global Sulfonamides Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Sulfonamides Market Size, 2021 & 2028
6.2 By Region - Global Sulfonamides Revenue & Forecasts
6.2.1 By Region - Global Sulfonamides Revenue, 2017-2022
6.2.2 By Region - Global Sulfonamides Revenue, 2023-2028
6.2.3 By Region - Global Sulfonamides Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sulfonamides Revenue, 2017-2028
6.3.2 US Sulfonamides Market Size, 2017-2028
6.3.3 Canada Sulfonamides Market Size, 2017-2028
6.3.4 Mexico Sulfonamides Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sulfonamides Revenue, 2017-2028
6.4.2 Germany Sulfonamides Market Size, 2017-2028
6.4.3 France Sulfonamides Market Size, 2017-2028
6.4.4 U.K. Sulfonamides Market Size, 2017-2028
6.4.5 Italy Sulfonamides Market Size, 2017-2028
6.4.6 Russia Sulfonamides Market Size, 2017-2028
6.4.7 Nordic Countries Sulfonamides Market Size, 2017-2028
6.4.8 Benelux Sulfonamides Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sulfonamides Revenue, 2017-2028
6.5.2 China Sulfonamides Market Size, 2017-2028
6.5.3 Japan Sulfonamides Market Size, 2017-2028
6.5.4 South Korea Sulfonamides Market Size, 2017-2028
6.5.5 Southeast Asia Sulfonamides Market Size, 2017-2028
6.5.6 India Sulfonamides Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sulfonamides Revenue, 2017-2028
6.6.2 Brazil Sulfonamides Market Size, 2017-2028
6.6.3 Argentina Sulfonamides Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sulfonamides Revenue, 2017-2028
6.7.2 Turkey Sulfonamides Market Size, 2017-2028
6.7.3 Israel Sulfonamides Market Size, 2017-2028
6.7.4 Saudi Arabia Sulfonamides Market Size, 2017-2028
6.7.5 UAE Sulfonamides Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Sulfonamides Major Product Offerings
7.1.4 Pfizer Sulfonamides Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Sulfonamides Major Product Offerings
7.2.4 Sanofi Sulfonamides Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Sulfonamides Major Product Offerings
7.3.4 Roche Sulfonamides Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 Mylan
7.4.1 Mylan Corporate Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Sulfonamides Major Product Offerings
7.4.4 Mylan Sulfonamides Revenue in Global Market (2017-2022)
7.4.5 Mylan Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Sulfonamides Major Product Offerings
7.5.4 Teva Sulfonamides Revenue in Global Market (2017-2022)
7.5.5 Teva Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Sulfonamides Major Product Offerings
7.6.4 Bayer Sulfonamides Revenue in Global Market (2017-2022)
7.6.5 Bayer Key News
7.7 Abbott
7.7.1 Abbott Corporate Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Sulfonamides Major Product Offerings
7.7.4 Abbott Sulfonamides Revenue in Global Market (2017-2022)
7.7.5 Abbott Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Sulfonamides Major Product Offerings
7.8.4 GlaxoSmithKline Sulfonamides Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporate Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Sulfonamides Major Product Offerings
7.9.4 Boehringer Ingelheim Sulfonamides Revenue in Global Market (2017-2022)
7.9.5 Boehringer Ingelheim Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES



REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount